Search

Your search keyword '"renin–angiotensin–aldosterone system"' showing total 2,554 results

Search Constraints

Start Over You searched for: Descriptor "renin–angiotensin–aldosterone system" Remove constraint Descriptor: "renin–angiotensin–aldosterone system"
2,554 results on '"renin–angiotensin–aldosterone system"'

Search Results

2. Walnut peptide relieves hypertension and associated kidney and heart injury by regulating the renin–angiotensin–aldosterone system and intestinal microbiota.

3. Untangling the Uncertain Role of Overactivation of the Renin–Angiotensin–Aldosterone System with the Aging Process Based on Sodium Wasting Human Models.

5. Pathophysiological role of Na–Cl cotransporter in kidneys, blood pressure, and metabolism.

6. Mineralocorticoid receptor antagonists in kidney transplantation.

7. Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats.

8. 单纯性肥胖儿童血清Leptin、25-(OH)D3与糖脂代谢、生长发育和肾素-血管紧张素-醛固酮系统的相关性分析.

9. Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum.

10. Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats

11. Cardiovascular Interactions of Renin-Angiotensin-Aldosterone System Assessed by Cardiac Magnetic Resonance: The Multi-Ethnic Study of Atherosclerosis.

13. The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke

14. Impaired angiotensin II signaling in septic shock

15. The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke.

16. Impaired angiotensin II signaling in septic shock.

17. Consensus statement on the management of hyperkalaemia—An Asia–Pacific perspective.

18. Mechanisms of Kidney Damage Development in Patients with New Coronavirus Infection: Literature Review.

19. Unveiling Selected Influences on Chronic Kidney Disease Development and Progression.

20. SIRT1在糖尿病心肌病发病中的研究进展.

21. LOCAL ALDOSTERONE RELEASE AND CYP11B2 EXPRESSION IN RESPONSE TO ANGIOTENSIN PEPTIDES, GLUCOSE, AND POTASSIUM - AN EX VIVO STUDY ON MURINE COLON.

22. Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)

23. Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design

24. The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function

25. Metabolic effects of aldosterone

26. Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease

27. Genetic Factors Contributing to the Pathogenesis of Essential Hypertension in Two African Populations.

28. Aldosterone and aldosterone synthase inhibitors in cardiorenal disease.

29. Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease.

30. The sympathetic nervous system in heart failure revisited.

31. The GLP-1-mediated gut-kidney cross talk in humans: mechanistic insight.

32. Histone Modifications and Their Contributions to Hypertension.

33. Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease.

34. Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms.

35. RAAS in diabetic retinopathy: mechanisms and therapies

36. A traditional Korean fermented food, Gochujang exerts anti-hypertensive effects, regardless of its high salt content by regulating renin-angiotensin-aldosterone system in SD rats

37. Reactive oxygen species impair Na+ transport and renal components of the renin-angiotensin-aldosterone system after paraquat poisoning

38. Significance of Haematological Variates in Determining Risk of Cardiovascular Complications Post SARS-CoV-2 Infection: A Prospective Cohort Study

39. The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review

40. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies

41. Untangling the Uncertain Role of Overactivation of the Renin–Angiotensin–Aldosterone System with the Aging Process Based on Sodium Wasting Human Models

42. Combining Bibliometric Analysis to Uncover the Detrimental and Protective Roles of Various Dendritic Cell Types in Cardiovascular Arterial Diseases

43. Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum

44. Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure

46. Soyasaponin I alleviates hypertensive intracerebral hemorrhage by inhibiting the renin-angiotensin-aldosterone system.

47. Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study.

48. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies.

49. Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)—Results From the MIRACLE HIV Study.

50. ACE2 PET in healthy and diseased conditions.

Catalog

Books, media, physical & digital resources